| ￥3300 | |
| Z05665-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by BisTris PAGE > 90% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 62.90 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 75-90 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of N Cadherin, His, Human is greater than 90% as determined by SEC-HPLC. »
N Cadherin, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Neural (N)-cadherin is a calcium-dependent single-chain transmembrane glycoprotein that mediates homotypic and heterotypic cell-cell adhesion. As an important member of the cadherin family, N-cadherin plays an important role in the developmental and functional regulation of the nervous system, brain, heart, skeletal muscles, blood vessels and hematopoietic microenvironment. |
| Synonyms | CDH2; N-cadherin; Neural cadherin; CD325; CDHN; CDw325; NCAD; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
